News & Views
Laboratory scientists develop new cancer-killing drug
May 11 2010
Described as a "breakthrough" by the Samuel Waxman Cancer Research Foundation, the treatment is a drug that targets an oncogene known as BCL6.
Associate professor of medicine at Weill Cornell Medical College in New York City Dr Alexander MacKerell said BCL6 is a protein that controls "thousands of other genes".
"Because of that, it has a very profound impact on cells and is required for lymphoma cells to survive and multiply," he explained.
According to the expert, current chemotherapy methods for large B cell lymphomas cure 60 per cent of patients, but it is hoped a larger number can be saved with the new medication.
It is possible that the drug may eventually negate the need for toxic treatments completely, he added.
Last month, laboratory scientists at Fox Chase Cancer Center revealed they may have found an innovative way to screen early for ovarian tumours.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE